Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126416171 | 12641617 | 1 | I | 20160728 | 20160810 | 20160810 | PER | US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-49985BP | BOEHRINGER INGELHEIM | 0.00 | F | Y | 0.00000 | 20160810 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126416171 | 12641617 | 1 | PS | MIRAPEX | PRAMIPEXOLE DIHYDROCHLORIDE | 1 | Oral | 20667 | .125 | MG | TABLET | ||||||||
| 126416171 | 12641617 | 2 | SS | MIRAPEX | PRAMIPEXOLE DIHYDROCHLORIDE | 1 | Oral | 20667 | .125 | MG | TABLET | ||||||||
| 126416171 | 12641617 | 3 | SS | MIRAPEX | PRAMIPEXOLE DIHYDROCHLORIDE | 1 | Oral | 20667 | .125 | MG | TABLET | ||||||||
| 126416171 | 12641617 | 4 | SS | MIRAPEX | PRAMIPEXOLE DIHYDROCHLORIDE | 1 | Oral | 0.5 MG | 20667 | .5 | MG | TABLET | QD | ||||||
| 126416171 | 12641617 | 5 | C | LYRICA | PREGABALIN | 1 | Unknown | 300 MG | 0 | 300 | MG | QD | |||||||
| 126416171 | 12641617 | 6 | C | FLAGYL | METRONIDAZOLEMETRONIDAZOLE HYDROCHLORIDE | 1 | Unknown | 0 | |||||||||||
| 126416171 | 12641617 | 7 | C | ZITHROMAX | AZITHROMYCIN DIHYDRATE | 1 | Oral | 250 MG | 0 | 250 | MG | TABLET | QD | ||||||
| 126416171 | 12641617 | 8 | C | NEURONTIN | GABAPENTIN | 1 | Oral | 1200 MG | 0 | 600 | MG | TABLET | BID | ||||||
| 126416171 | 12641617 | 9 | C | NEURONTIN | GABAPENTIN | 1 | Oral | 0 | 1200 | MG | TABLET | ||||||||
| 126416171 | 12641617 | 10 | C | WELLBUTRIN | BUPROPION HYDROCHLORIDE | 1 | Oral | 300 MG | 0 | 300 | MG | TABLET | QD | ||||||
| 126416171 | 12641617 | 11 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Oral | 0 | 88 | UG | TABLET | ||||||||
| 126416171 | 12641617 | 12 | C | CYTOMEL | LIOTHYRONINE SODIUM | 1 | Oral | 0 | 25 | UG | TABLET | ||||||||
| 126416171 | 12641617 | 13 | C | VYVANSE | LISDEXAMFETAMINE DIMESYLATE | 1 | Oral | 20 MG | 0 | 20 | MG | CAPSULE | QD | ||||||
| 126416171 | 12641617 | 14 | C | RITALIN | METHYLPHENIDATE HYDROCHLORIDE | 1 | Oral | 20 MG | 0 | 20 | MG | CAPSULE | |||||||
| 126416171 | 12641617 | 15 | C | LOESTRIN NOS | ETHINYL ESTRADIOLNORETHINDRONE ACETATE | 1 | Oral | STRENGTH: 1.5 / 30 MG -MCG | 0 | TABLET | |||||||||
| 126416171 | 12641617 | 16 | C | VALTREX | VALACYCLOVIR HYDROCHLORIDE | 1 | Oral | 0 | 1 | G | TABLET | ||||||||
| 126416171 | 12641617 | 17 | C | METADATE CD | METHYLPHENIDATE HYDROCHLORIDE | 1 | Oral | 30 MG | 0 | 30 | MG | CAPSULE | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126416171 | 12641617 | 1 | Product used for unknown indication |
| 126416171 | 12641617 | 5 | Product used for unknown indication |
| 126416171 | 12641617 | 6 | Product used for unknown indication |
| 126416171 | 12641617 | 7 | Product used for unknown indication |
| 126416171 | 12641617 | 8 | Product used for unknown indication |
| 126416171 | 12641617 | 10 | Product used for unknown indication |
| 126416171 | 12641617 | 11 | Product used for unknown indication |
| 126416171 | 12641617 | 12 | Product used for unknown indication |
| 126416171 | 12641617 | 13 | Product used for unknown indication |
| 126416171 | 12641617 | 14 | Product used for unknown indication |
| 126416171 | 12641617 | 15 | Product used for unknown indication |
| 126416171 | 12641617 | 16 | Product used for unknown indication |
| 126416171 | 12641617 | 17 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126416171 | 12641617 | Restless legs syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |